Evidence map›Paper›PMID 39999169›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Computational biology predicts metabolic engineering targets for increased production of 103 valuable chemicals in yeast.

Iván Domenzain, Yao Lu, Haoyu Wang, Junling Shi, Hongzhong Lu, Jens Nielsen

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Systems biology of yeast metabolism.FEMS yeast research · 2026
    Review
  3. Review
  4. Article
  5. The Power of Yeast.Yeast (Chichester, England) · 2025
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Iván Domenzain *Department of Life Sciences, Chalmers University of Technology, Gothenburg SE41296, Sweden.ORCID 0000-0002-5322-2040
Yao Lu *College of Enology, Northwest A&F University, Yangling, Shannxi 712100, China.
Haoyu WangState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.ORCID 0009-0006-6237-9628
Junling ShiKey Laboratory for Space Bioscience and Biotechnology, School of Life Sciences, Northwstern Polytechnical University, Xi'an, Shaanxi 710072, China.
Hongzhong LuState Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai 200240, China.
Jens NielsenDepartment of Life Sciences, Chalmers University of Technology, Gothenburg SE41296, Sweden.ORCID 0000-0002-9955-6003

Funding

EC Horizon 2020 686070EC Horizon 2020 720824Novo Nordisk Foundation NNF10CC1016517
6 · The paper itself

Abstract

Development of efficient cell factories that can compete with traditional chemical production processes is complex and generally driven by case-specific strategies, based on the product and microbial host of interest. Despite major advancements in the field of metabolic modeling in recent years, prediction of genetic modifications for increased production remains challenging. Here, we present a computational pipeline that leverages the concept of protein limitations in metabolism for prediction of optimal combinations of gene engineering targets for enhanced chemical bioproduction. We used our pipeline for prediction of engineering targets for 103 different chemicals using

Indexed as

Computational BiologyMetabolic EngineeringSaccharomyces cerevisiaeMetabolic Networks and PathwaysModels, BiologicalSaccharomyces cerevisiae ProteinsSaccharomyces cerevisiae Proteinsgenome scale modelingmetabolic engineeringsynthetic biologyyeast

Identifiers

PMID39999169
PMCPMC11892653

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.